Home » Authors » Brady Huggett

Articles by Brady Huggett

Europeans Continue Struggling To Blend The Colors Of Biotech

Dec. 3, 2003

By Brady Huggett

Europeans Continue Struggling To Blend The Colors Of Biotech

Dec. 3, 2003

By Brady Huggett

Protein Forest's Series A Raises $19M For ProteomeChip Launch

Nov. 24, 2003

By Brady Huggett

Protein Forest's Series A Raises $19M For ProteomeChip Launch

Nov. 24, 2003

By Brady Huggett

With Phase III Ongoing, Repligen Presents Preclinical Secretin Data

Nov. 13, 2003

By Brady Huggett

With Phase III Ongoing, Repligen Presents Preclinical Secretin Data

Nov. 13, 2003

By Brady Huggett

Corixa Reports Third-Quarter Results, Restructuring Plans

Nov. 10, 2003

By Brady Huggett

Corixa Reports Third-Quarter Results, Restructuring Plans

Nov. 10, 2003

By Brady Huggett

Pursuing Growth Via Acquisition Strategy, Invitrogen Buys Sequitur

Nov. 6, 2003

By Brady Huggett

Pursuing Growth Via Acquisition Strategy, Invitrogen Buys Sequitur

Nov. 6, 2003

By Brady Huggett

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 27, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 27, 2024.
In muscular dystrophies, gene therapies race the clock
BioWorld
Since the isolation of the gene that causes Duchenne muscular dystrophy (DMD), scientists have progressed in understanding the mechanisms that lead to muscular...
Bridgebio, with FDA approval, faces Pfizer in ATTR
BioWorld
With the U.S. FDA approval of Attruby (acoramidis) for transthyretin amyloidosis with cardiomyopathy (ATTR-CM), Bridgebio Pharma Inc. is taking on an industry...
‘Evo’ AI can design complete genomes
BioWorld Science
The development of new machine learning tools like Alphafold and Rfdiffusion has allowed scientists to predict the structure of proteins and design them for drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.